| Literature DB >> 31327075 |
Kay Diederen1, Lissy de Ridder2, Patrick van Rheenen3, Victorien M Wolters4, Maria L Mearin5, Tim G de Meij6, Herbert van Wering7, Matthijs W Oomen8, Justin R de Jong8, Cornelius E Sloots9, Marc A Benninga10, Angelika Kindermann10.
Abstract
Psychosocial and functional outcomes after intestinal resection in pediatric Crohn's disease (CD) are lacking. Therefore, we (I) assessed health-related quality of life (HRQOL), colorectal function, and satisfaction with surgery and (II) investigated their relationship with surgical outcomes, after ileocecal resection for CD. Crohn's patients that underwent ileocecal resection during childhood were included. HRQOL and colorectal function were assessed using SF-36 and COREFO, respectively, and compared with reference values. Satisfaction was scored on a 5-point Likert scale. In total, 80 patients (50% male, median age 23.0 years) were included. Physical HRQOL was impaired (SF-36 [mean]: CD, 47 vs. general, 54; p < 0.001), while mental HRQOL was similar to that in the general population. Overall colorectal function was impaired (COREFO [mean]: CD, 12.6 vs. normal, 7.2; p < 0.001). Worse colorectal function was associated with increasing clinical disease activity and longer interval since resection. Majority of patients was satisfied with surgery (81% satisfied/very satisfied, 11% neither satisfied nor dissatisfied, 8% dissatisfied/very dissatisfied). Decreased satisfaction with surgery was associated with increased clinical disease activity but not related to colorectal function.Conclusions: Physical HRQOL and colorectal function in CD patients who underwent ileocecal resection during childhood seem impaired and related to adverse surgical outcomes. This emphasizes the need for post-operative monitoring and prophylactic therapies. What is Known: • Up to 25% of pediatric-onset Crohn's disease (CD) patients undergo an intestinal resection within 5 years from diagnosis. • Many children and adults with CD experience disruption of their daily activities and health-related quality of life (HRQOL). What is New: • Physical HRQOL and colorectal function are impaired in patient with CD that underwent ileocecal resection during childhood. • Increasing clinical disease activity, a longer interval since surgery, severe complications related to surgery, and recurrent surgeries are all associated with worse colorectal function.Entities:
Keywords: Colorectal function.; Crohn’s disease; Intestinal resection; Pediatric; Quality of life; Surgery
Year: 2019 PMID: 31327075 PMCID: PMC6694081 DOI: 10.1007/s00431-019-03427-3
Source DB: PubMed Journal: Eur J Pediatr ISSN: 0340-6199 Impact factor: 3.183
Demographic and surgical characteristics of pediatric Crohn’s disease patients at the time of ileocecal resection
| Responders ( | |
|---|---|
| Male ( | 50 (50%) |
| Age, surgery (median, IQR) | 15.0 (14.0–16.0) |
| Age, follow-up (median, IQR) | 23.0 (18.5–30.0) |
| Age at diagnosisa | |
| A1a, < 10 years ( | 7 (9%) |
| A1b, 10–17 years ( | 73 (91%) |
| Disease location, terminal ileum—colona | |
| L1, distal 1/3 ileum ± limited cecum ( | 49 (61%) |
| L2, colonic ( | 0 (0%) |
| L3, ileocolonic ( | 31 (39%) |
| Disease location, upper gastrointestinala,b (L4a/L4b) | 25 (31%) |
| Disease behaviora | |
| B1, non-stricturing, non-penetrating ( | 14 (18%) |
| B2, stricturing ( | 32 (40%) |
| B3, penetrating ( | 9 (11%) |
| B2B3, stricturing and penetrating ( | 25 (31%) |
| Perianal diseasea ( | 18 (23%) |
| Medical therapy ever used before surgery | |
| Steroids ( | 62 (78%) |
| Anti-TNF-α ( | 30 (38%) |
| Immunomodulators ( | 59 (74%) |
| Mesalazine ( | 35 (44%) |
| Surgical access | |
| Open ( | 32 (42%) |
| Laparoscopy ( | 44 (58%) |
| Anastomosis, type | |
| End-to-end ( | 55 (68%) |
| End-to-side ( | 5 (7%) |
| Side-to-side ( | 16 (20%) |
| Anastomosis, suture technique | |
| Hand-sewn ( | 64 (88%) |
| Stapled ( | 9 (12%) |
| Primary ileostomy ( | 2 (2.5%) |
| Additional procedures ( | 9 (11%) |
| Resection specimen | |
| Length (cm) (median, IQR) | 24.0 (18.0–32.0) |
| Resection margin positivityc ( | 44 (55%) |
| Emergency surgery ( | 3 (4%) |
| Months of follow-up (median, IQR) | 81.0 (20.5–163.0) |
aAccording to the Paris classification
bL4a, upper disease proximal to ligament of Treitz; L4b, upper disease distal to ligament of Treitz and proximal to distal 1/3 ileum
cMicroscopically positive resection margins
anti-TNFα, anti-tumor necrosis factor alpha
Variables containing missing data in included patients (n = 80): preoperative medication n = 1 (1%); immunomodulators n = 1 (1%); mesalazine n = 1 (1%); access n = 4 (5%); anastomosis, type n = 4 (5%); anastomosis, suture technique n = 7 (9%); resection specimen (length) n = 1 (1%); resection specimen (resection margin positivity) n = 7 (9%), emergency surgery n = 1 (1%)
Fig. 1Health-related quality of life measured with the short form 36 in patients with ileocecal resection in clinical remission and with active disease, compared with subjects in the general population
COREFO total and category scores in patients with CD in remission and active disease compared with a cohort with normal colorectal function
| Normal colorectal function mean (SD) | Ileocecal resection | ||||
|---|---|---|---|---|---|
| Remission mean diff. (95%CI) | Cohen’s | Active disease mean diff. (95%CI) | Cohen’s | ||
| Incontinence | 5.6 (7.5) | − 2.9 (− 0.1–5.8) | 0.46 | + 4.9 (0.7–9.0)* | 0.52 |
| Frequency | 6.2 (8.8) | + 2.8 (− 1.4–7.1) | 0.33 | +17.7 (11.8–23.6)* | 1.24 |
| Stool-related aspects | 7.7 (12.9) | + 2.4 (− 4.4–9.1) | 0.16 | + 22.2 (12.8–31.7)* | 1.05 |
| Need for medication | 6.1 (15.6) | + 1.7 (− 5.7–9.0) | 0.11 | + 25.7 (15.4–36.1)* | 1.07 |
| Social impact | 4.9 (7.9) | +5.8 (1.12–10.5)* | 0.60 | + 35.6 (29.1–42.2)* | 2.27 |
| Total score | 7.2 (7.0) | + 0.5 (− 2.8–3.8) | 0.08 | + 19.4 (14.8–24.0)* | 1.79 |
COREFO, colorectal function outcome; SD, standard deviation; 95%CI, 95% confidence interval
*Significant difference (p < 0.01)
Association between patient and surgical characteristics and COREFO total and subscores
| Incontinence B (95% CI) | Need for medication B (95%CI) | Frequency B (95%CI) | Stool-related aspects B (95%CI) | Social impact B (95%CI) | Total score B (95%CI) | |
|---|---|---|---|---|---|---|
| Clinical disease activitya | 0.17 (0.02–0.34)* | 0.22 (0.01–0.41)* | 0.31 (0.14–0.47)* | 0.24 (0.02–0.47)* | 0.35 (0.19–0.52)* | 0.27(0.16–0.39)* |
| Time since resection (months) | 0.46 (− 0.03–0.95) | 0.46 (− 0.15–1.08) | 0.67 (0.13–1.21)* | 0.17 (−0.53–0.88) | 0.46 (−0.06–0.97) | 0.40 (0.05–0.75)* |
| Length of resection (cm) | – | – | – | – | – | – |
Complications surgeryb Yes vs. no | – | 0.35 (− 0.09–0.80) | 0.40 (0.02–0.79)* | – | – | – |
Surgical recurrencec Yes vs. no | 0.13 (− 0.22–0.47) | 0.52 (0.09–0.95)* | – | 0.16 (−0.34–0.65) | 0.16 (−0.20–0.53) | 0.13 (−0.12–0.37) |
COREFO, colorectal function outcome
*Significantly associated with multivariable regression analysis, corrected for sex and age at follow-up (p < 0.05). Variables with a p value of ≥ 0.1 in univariable analysis are indicated by (−) and excluded from multivariable analysis
aCategorical disease activity: remission, mild, moderate, and severe.
bClavien-Dindo classification grade ≥ III (requiring surgical, endoscopic, or radiological intervention)
cDisease recurrence requiring new resection for active inflammation or strictureplasty for (anastomotic) strictures
| |
|